"Boltz is a biotech exponential" — molecular tokens up 50x since June
GabriCorso · x · 2026-11-18
tomprimozic calls Boltz "a biotech exponential", pointing to the growth curve of molecular tokens processed for paying customers.
More from Venture
- Perplexity turns Anthropic's S-1 into an interactive 3D-chart explainer — jeffgrimes9 · 2026-11-18
- Boltz, the AI lab that moved from MIT to the UK, raises $110M — GabriCorso · 2026-11-18
- 49% of CIOs over token budget: Microsoft made AI cost control the product at Ignite — BenBajarin · 2026-11-18
- Industry figures congratulate Boltz on its $110M Series A — GabriCorso · 2026-11-18
- TSMC now demanding cash upfront to secure capacity as AI demand strains supply chain — ctjlewis · 2026-11-18
- Boltz raises $110M Series A as pharma usage of its AI drug design platform grows 50x — a16z · 2026-11-18